Plant ID: NPO7513
Plant Latin Name: Cannabis Sativa
Taxonomy Genus: Cannabis
Taxonomy Family: Cannabaceae
NCBI TaxonomyDB:
3483
Plant-of-the-World-Online:
n.a.
Analgesic; Anodyne; Anthelmintic; Antianxiety; Antibacterial; Anticonvulsant; Antiemetic; Antiperiodic; Antirheumatic; Antispasmodic; Cancer; Cholagogue; Demulcent; Diuretic; Emmenagogue; Emollient; Febrifuge; Hypnotic; Laxative; Narcotic; Ophthalmic; Sedative; Tonic
India; China; Thailand
Ingredient ID: NPC99836
Ingredient ID: NPC97377
Ingredient ID: NPC96940
Ingredient ID: NPC94196
Ingredient ID: NPC92855
Ingredient ID: NPC90566
Ingredient ID: NPC90232
Ingredient ID: NPC8973
Ingredient ID: NPC85813
Ingredient ID: NPC85117
Ingredient ID: NPC77272
Ingredient ID: NPC77249
Ingredient ID: NPC76828
Ingredient ID: NPC66383
Ingredient ID: NPC65839
Ingredient ID: NPC65455
Ingredient ID: NPC62599
Ingredient ID: NPC57279
Ingredient ID: NPC5413
Ingredient ID: NPC48853
Ingredient ID: NPC485093
Ingredient ID: NPC476254
Ingredient ID: NPC476171
Ingredient ID: NPC475831
Ingredient ID: NPC475782
Ingredient ID: NPC474373
Ingredient ID: NPC474372
Ingredient ID: NPC474016
Ingredient ID: NPC472800
Ingredient ID: NPC472799
Ingredient ID: NPC472798
Ingredient ID: NPC472797
Ingredient ID: NPC472796
Ingredient ID: NPC472795
Ingredient ID: NPC46300
Ingredient ID: NPC424
Ingredient ID: NPC4147
Ingredient ID: NPC39362
Ingredient ID: NPC38604
Ingredient ID: NPC37299
Ingredient ID: NPC313673
Ingredient ID: NPC30506
Ingredient ID: NPC300956
Ingredient ID: NPC299568
Ingredient ID: NPC29831
Ingredient ID: NPC294548
Ingredient ID: NPC293551
Ingredient ID: NPC290803
Ingredient ID: NPC287624
Ingredient ID: NPC286111
Ingredient ID: NPC284371
Ingredient ID: NPC278683
Ingredient ID: NPC27534
Ingredient ID: NPC272241
Ingredient ID: NPC270087
Ingredient ID: NPC26974
Ingredient ID: NPC26229
Ingredient ID: NPC261831
Ingredient ID: NPC257124
Ingredient ID: NPC252095
Ingredient ID: NPC249669
Ingredient ID: NPC241976
Ingredient ID: NPC241973
Ingredient ID: NPC24101
Ingredient ID: NPC240343
Ingredient ID: NPC239039
Ingredient ID: NPC23694
Ingredient ID: NPC235251
Ingredient ID: NPC234106
Ingredient ID: NPC232223
Ingredient ID: NPC230085
Ingredient ID: NPC223267
Ingredient ID: NPC218753
Ingredient ID: NPC217447
Ingredient ID: NPC217336
Ingredient ID: NPC216630
Ingredient ID: NPC216127
Ingredient ID: NPC21157
Ingredient ID: NPC211179
Ingredient ID: NPC209970
Ingredient ID: NPC207420
Ingredient ID: NPC201662
Ingredient ID: NPC195749
Ingredient ID: NPC188844
Ingredient ID: NPC178435
Ingredient ID: NPC176300
Ingredient ID: NPC171736
Ingredient ID: NPC1682
Ingredient ID: NPC16577
Ingredient ID: NPC1656
Ingredient ID: NPC163524
Ingredient ID: NPC160623
Ingredient ID: NPC159754
Ingredient ID: NPC159630
Ingredient ID: NPC154932
Ingredient ID: NPC153958
Ingredient ID: NPC150928
Ingredient ID: NPC14930
Ingredient ID: NPC149184
Ingredient ID: NPC148984
Ingredient ID: NPC146197
Ingredient ID: NPC143326
Ingredient ID: NPC14013
Ingredient ID: NPC136014
Ingredient ID: NPC13451
Ingredient ID: NPC132043
Ingredient ID: NPC130245
Ingredient ID: NPC118885
Ingredient ID: NPC113907
Ingredient ID: NPC10645
Ingredient ID: NPC105493
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Cysteine protease | CASP6 | Caspase-6 | P55212 | CHEMBL3308 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 | Cytochrome P450 family 2 | CYP2B6 | Cytochrome P450 2B6 | P20813 | CHEMBL4729 |
Cytochrome P450 | Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 | Cytochrome P450 family 3 | CYP3A5 | Cytochrome P450 3A5 | P20815 | CHEMBL3019 |
Therapeutic Target | Enzyme | AKR1C3 | Aldo-keto-reductase family 1 member C3 | P42330 | CHEMBL4681 |
Therapeutic Target | Fatty acid binding protein family | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Therapeutic Target | Fatty acid binding protein family | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Therapeutic Target | Oxidoreductase | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Therapeutic Target | Small molecule receptor (family A GPCR) | GPR55 | G-protein coupled receptor 55 | Q9Y2T6 | CHEMBL1075322 |
Therapeutic Target | Small molecule receptor (family A GPCR) | HTR2C | Serotonin 2c (5-HT2c) receptor | P28335 | CHEMBL225 |
Therapeutic Target | Small molecule receptor (family A GPCR) | FFAR1 | Free fatty acid receptor 1 | O14842 | CHEMBL4422 |
Therapeutic Target | Small molecule receptor (family A GPCR) | CHRM4 | Muscarinic acetylcholine receptor M4 | P08173 | CHEMBL1821 |
Therapeutic Target | Small molecule receptor (family A GPCR) | DRD3 | Dopamine D3 receptor | P35462 | CHEMBL234 |
Therapeutic Target | Small molecule receptor (family A GPCR) | FFAR4 | G-protein coupled receptor 120 | Q5NUL3 | CHEMBL5339 |
Therapeutic Target | Small molecule receptor (family A GPCR) | CNR2 | Cannabinoid CB2 receptor | P34972 | CHEMBL253 |
Therapeutic Target | Small molecule receptor (family A GPCR) | CNR1 | Cannabinoid CB1 receptor | P21554 | CHEMBL218 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 236 | |
Plant level | 43 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT05283161 | CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) | fibromyalgia | Cannabidiol (NPC299568) | NP level |
NCT04590495 | The Effects of Cannabidiol on the Driving Ability of Healthy Adults | Cognitive impairment | Cannabidiol (NPC299568) | NP level |
NCT02006628 | A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT04741477 | The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products | Cannabis|Drug Effect | Cannabis Sativa | Plant level As plant Extract |
NCT04193631 | Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain | pain | Cannabidiol (NPC299568) | NP level |
NCT01776970 | Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease | amyotrophic lateral sclerosis | Cannabidiol (NPC299568) | NP level |
NCT02318563 | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome | Dravet syndrome | Cannabidiol (NPC299568) | NP level |
NCT03245658 | The Effect of Cannabis in Pancreatic Cancer | Neoplasms Pancreatic|Cachexia; Cancer|Cannabis|Appetite Loss|Palliative Medicine|Morbidity|Mortality | Cannabis Sativa | Plant level As single plant |
NCT04729179 | Cannabidiol for Fibromyalgia (The CANNFIB Trial) | fibromyalgia | Cannabidiol (NPC299568) | NP level |
NCT02892591 | Cannabis Versus Oxycodone for Pain Relief | Back pain;Neck pain | Cannabinol (NPC16577) | NP level |
NCT01969474 | Effectiveness of Cannabis in the Treatment of Tinnitus Patients | Tinnitus | Cannabis Sativa | Plant level As single plant |
NCT05288283 | Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures | Seizure | Cannabidiol (NPC299568) | NP level |
NCT03929835 | Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa | Hidradenitis Suppurativa | Cannabis Sativa | Plant level As plant Extract |
NCT05283161 | CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) | fibromyalgia | Cannabinol (NPC16577) | NP level |
NCT04044729 | Mechanisms of CBD for Chronic Pain | Chronic pain | Cannabidiol (NPC299568) | NP level |
NCT03766971 | Influence of Tobacco Use on Cannabis Use | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT01605539 | Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans | opioid dependence | Cannabidiol (NPC299568) | NP level |
NCT02224560 | Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT05212493 | The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder | autism spectrum disorder | Cannabinol (NPC16577) | NP level |
NCT01555983 | Vaporized Cannabis and Spinal Cord Injury Pain | Spinal cord injury | Cannabinol (NPC16577) | NP level |
NCT02548559 | Sublingual Cannabidiol for Anxiety | anxiety | Cannabidiol (NPC299568) | NP level |
NCT02783092 | A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT05337033 | Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial | Chronic Migraine | Cannabis Sativa | Plant level As single plant |
NCT00254761 | Effects of Smoked Marijuana on Neuropathic Pain | neuropathic pain | Cannabinol (NPC16577) | NP level |
NCT04267679 | Cannabidiol for Anxiety | anxiety | Cannabidiol (NPC299568) | NP level |
NCT04752813 | A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB) | glioblastoma multiforme | Phytonadione (NPC188844) | NP level |
NCT03690791 | Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease | amyotrophic lateral sclerosis | Cannabidiol (NPC299568) | NP level |
NCT03639064 | Cannabis Oil for Pain in Parkinson's Disease | Parkinson disease | Cannabinol (NPC16577) | NP level |
NCT02324777 | Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee | osteoarthritis, knee | Cannabinol (NPC16577) | NP level |
NCT02286986 | Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT05407285 | A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05351801 | Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain | neuropathic pain | Cannabidiol (NPC299568) | NP level |
NCT00029679 | Borage Oil and Ginkgo Biloba (EGb 761) in Asthma | asthma | Linoleic Acid (NPC85813);Gamolenic Acid (NPC5413) | NP level |
NCT05002114 | Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain. | Arthralgia | Cannabidiol (NPC299568) | NP level |
NCT04676035 | The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole | prostate cancer | Phytonadione (NPC188844) | NP level |
NCT01502046 | Neuroprotection by Cannabinoids in Huntington's Disease | Huntington disease | Cannabidiol (NPC299568);Cannabinol (NPC16577) | NP level |
NCT05320367 | A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT02955329 | Vaping THC From Electronic Cigarettes | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04601207 | A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00255580 | Medicinal Cannabis for Painful HIV Neuropathy | Neuropathic Pain | Cannabis Sativa | Plant level As single plant |
NCT03582137 | A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease | Parkinson Disease | Cannabis Sativa | Plant level As plant Extract |
NCT00260741 | Cannabis for Spasticity in Multiple Sclerosis | Multiple Sclerosis | Cannabis Sativa | Plant level As single plant |
NCT03635593 | Cannabis Oil for Chronic Non-Cancer Pain Treatment | Chronic pain | Cannabidiol (NPC299568) | NP level |
NCT05257044 | Acute Effects of Cannabigerol | anxiety | Cannabigerol (NPC201662) | NP level |
NCT03274440 | Effects of Marijuana on Symptoms of OCD | Obsessive-Compulsive Disorder | Cannabis Sativa | Plant level As single plant |
NCT04412837 | The Use of Cannabinoid Patch for Knee Osteoarthritis | osteoarthritis | Cannabidiol (NPC299568) | NP level |
NCT04977986 | Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome | fragile X syndrome | Cannabidiol (NPC299568) | NP level |
NCT01040910 | Cannabis for Inflammatory Bowel Disease | Crohn's disease;ulcerative colitis | Cannabinol (NPC16577) | NP level |
NCT03972124 | Cannabis for the Prophylactic Treatment of Migraine | migraine disorder | Cannabidiol (NPC299568) | NP level |
NCT04428203 | Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | prostate adenocarcinoma | Cannabidiol (NPC299568) | NP level |
NCT04192370 | Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine | opioid use disorder | Cannabidiol (NPC299568) | NP level |
NCT03825965 | Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT | osteoarthritis | Cannabidiol (NPC299568) | NP level |
NCT02332655 | Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome | Sturge-Weber syndrome | Cannabidiol (NPC299568) | NP level |
NCT03664141 | Impact of Cannabis Oil on Nutrition in Hemodialysis Patients Study (ICON-HP Study) | marasmus | Cannabinol (NPC16577) | NP level |
NCT03253926 | Effect of Lorcaserin on Cannabis Withdrawal and Self-administration | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04280289 | CBD Cannabis Extract: Pharmacokinetic Studies | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT05276232 | Detection of Cannabis Impairment With ISBRG's SpotLight-THC | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05306249 | Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients | HIV infection | Cannabidiol (NPC299568) | NP level |
NCT03617692 | Cannabis Use in Cancer Patients | Solid Tumor;Adult | Cannabis Sativa | Plant level As single plant |
NCT05427630 | Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment | Migraine|Cannabis|THC | Cannabis Sativa | Plant level As plant Extract |
NCT05413187 | A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder | Autistic Disorder | Cannabis Sativa | Plant level As single plant |
NCT02255292 | A Study: Pure CBD as Single-agent for Solid Tumor. | neoplasm | Cannabidiol (NPC299568) | NP level |
NCT03099005 | Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain | Cannabis|HIV Neuropathy|Pain Syndrome | Cannabis Sativa | Plant level As plant Extract |
NCT03247244 | Safety and Efficacy of Cannabis in Tourette Syndrome | Tourette syndrome | Cannabinol (NPC16577) | NP level |
NCT04447846 | Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome | Sturge-Weber syndrome | Cannabidiol (NPC299568) | NP level |
NCT04982029 | Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder | opioid use disorder | Cannabidiol (NPC299568) | NP level |
NCT03840512 | An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD) | graft versus host disease | Cannabidiol (NPC299568) | NP level |
NCT04721691 | Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES). | status epilepticus | Cannabidiol (NPC299568) | NP level |
NCT05269459 | Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults | post-traumatic stress disorder | Cannabidiol (NPC299568) | NP level |
NCT00373295 | Effect of Baclofen on Marijuana Withdrawal and Relapse | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT02224703 | GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome | Dravet syndrome | Cannabidiol (NPC299568) | NP level |
NCT03467113 | A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol | Dravet syndrome | Cannabidiol (NPC299568) | NP level |
NCT02318602 | Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder | Seizure | Cannabidiol (NPC299568) | NP level |
NCT04642404 | CBD for Dental Pain | toothache | Cannabidiol (NPC299568) | NP level |
NCT04883255 | Cannabis Use, Cognition, and the Endocannabinoid System in HIV | HIV-1 infection | Cannabidiol (NPC299568) | NP level |
NCT00260741 | Cannabis for Spasticity in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT04238754 | Oral Cannabidiol for Opioid Withdrawal | opioid dependence;opioid use disorder | Cannabidiol (NPC299568) | NP level |
NCT03518801 | Cannabidiol and Prolonged Exposure | post-traumatic stress disorder | Cannabidiol (NPC299568) | NP level |
NCT02559167 | Cannabidiol and Cocaine Craving/Dependence | cocaine dependence | Cannabidiol (NPC299568) | NP level |
NCT05159830 | Cannabidiol for Reducing Drinking in Alcohol Use Disorder | alcohol dependence | Cannabidiol (NPC299568) | NP level |
NCT02044809 | Cannabidiol: a Novel Intervention for Cannabis Use Problems? | cannabis dependence | Cannabidiol (NPC299568) | NP level |
NCT04873453 | CBD for the Treatment of Alcohol Use Disorder | alcohol dependence | Cannabidiol (NPC299568) | NP level |
NCT01284634 | Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease | Hepatic steatosis | Cannabidiol (NPC299568) | NP level |
NCT03328676 | The Effect of Cannabis on Dementia Related Agitation and Aggression | Agitation Related to Dementia | Cannabis Sativa | Plant level As single plant |
NCT05273775 | A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers | chronic hepatitis B virus infection | Phytonadione (NPC188844) | NP level |
NCT05346562 | Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients | hypertension | Cannabidiol (NPC299568) | NP level |
NCT03172741 | The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis | Multiple Sclerosis | Cannabis Sativa | Plant level As single plant |
NCT05413187 | A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder | autism | Cannabinol (NPC16577) | NP level |
NCT00781001 | Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy | Painful Diabetic Neuropathy | Cannabis Sativa | Plant level As plant Extract |
NCT03388970 | Vitamin K1 in the Treatment of Spontaneous Intracerebral Hemorrhage | intracerebral hemorrhage | Phytonadione (NPC188844) | NP level |
NCT02083874 | Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study | cannabis dependence | Cannabidiol (NPC299568) | NP level |
NCT01596075 | Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation | graft versus host disease | Cannabidiol (NPC299568) | NP level |
NCT03522324 | Pain Research: Innovative Strategies With Marijuana | Chronic Pain|Chronic Low Back Pain|Cannabis Use | Cannabis Sativa | Plant level As single plant |
NCT01562314 | A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160) | ulcerative colitis | Cannabidiol (NPC299568) | NP level |
NCT04286594 | A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety | anxiety | Cannabidiol (NPC299568) | NP level |
NCT05288010 | CANPAIN Feasibility Study Pragmatic Real World Trial Investigating CBMP in Chronic Pain Patients | Chronic pain | Cannabinol (NPC16577) | NP level |
NCT05283382 | Cannabidiol Effects on Learning and Anxiety | anxiety | Cannabidiol (NPC299568) | NP level |
NCT02318537 | CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults | Lennox-Gastaut syndrome | Cannabidiol (NPC299568) | NP level |
NCT04582591 | Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy | peripheral neuropathy | Cannabidiol (NPC299568) | NP level |
NCT03805750 | Trial of Cannabis for Essential Tremor | Essential Tremor | Cannabis Sativa | Plant level As single plant |
NCT00248378 | Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis | Multiple Sclerosis | Cannabis Sativa | Plant level As single plant |
NCT02324673 | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders | Seizure | Cannabidiol (NPC299568) | NP level |
NCT04088929 | The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy | diabetic neuropathy | Cannabidiol (NPC299568) | NP level |
NCT03900923 | Cannabidiol for ASD Open Trial | autism spectrum disorder | Cannabidiol (NPC299568) | NP level |
NCT00552604 | MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study | Spasticity | Cannabinol (NPC16577) | NP level |
NCT05670353 | Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND) | Endometriosis|Pelvic Pain | Cannabis Sativa | Plant level As plant Extract |
NCT04520685 | CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr | autism spectrum disorder | Cannabidiol (NPC299568) | NP level |
NCT05457465 | Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder | bipolar disorder | Cannabidiol (NPC299568) | NP level |
NCT01037322 | Cannabidiol for Inflammatory Bowel Disease | Crohn's disease;ulcerative colitis | Cannabidiol (NPC299568) | NP level |
NCT05240755 | Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery | pain | Cannabidiol (NPC299568) | NP level |
NCT04421456 | Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT02177513 | Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT02224690 | A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P | Lennox-Gastaut syndrome | Cannabidiol (NPC299568) | NP level |
NCT03877991 | Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations | pain | Cannabidiol (NPC299568) | NP level |
NCT03274440 | Effects of Marijuana on Symptoms of OCD | obsessive-compulsive disorder | Cannabinol (NPC16577) | NP level |
NCT04992624 | Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee | osteoarthritis, knee | Cannabidiol (NPC299568) | NP level |
NCT05049733 | The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A | cannabis dependence | Cannabidiol (NPC299568) | NP level |
NCT00628290 | Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT05490511 | Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus | kidney disease | Cannabidiol (NPC299568) | NP level |
NCT01385124 | Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation | graft versus host disease | Cannabidiol (NPC299568) | NP level |
NCT02607904 | An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT05387148 | The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence | alcohol dependence | Cannabidiol (NPC299568) | NP level |
NCT01037322 | Cannabidiol for Inflammatory Bowel Disease | Crohn's Disease|Ulcerative Colitis | Cannabis Sativa | Plant level As plant Extract |
NCT03614663 | Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX) | fragile X syndrome | Cannabidiol (NPC299568) | NP level |
NCT03808935 | Cannabis Extract in Refractory Epilepsy Study | epilepsy | Cannabinol (NPC16577) | NP level |
NCT01742273 | Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients | cardiovascular disease | Phytonadione (NPC188844) | NP level |
NCT05114460 | Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal | opioid dependence | Cannabinol (NPC16577) | NP level |
NCT02564952 | An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT00308555 | Opioid and Cannabinoid Pharmacokinetic Interactions | Pain | Cannabis Sativa | Plant level As plant Extract |
NCT01528800 | Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients | chronic kidney disease | Phytonadione (NPC188844) | NP level |
NCT04360044 | Efficacy of Inhaled Cannabis for Acute Migraine Treatment | Migraine|Cannabis|THC|CBD | Cannabis Sativa | Plant level As plant Extract |
NCT03948074 | Cannabis For Cancer-Related Symptoms | Pain|Nausea|Anxiety|Sleep Disturbance | Cannabis Sativa | Plant level As single plant |
NCT03582137 | A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease | Parkinson disease | Cannabidiol (NPC299568) | NP level |
NCT04252586 | A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | Rett syndrome | Cannabidiol (NPC299568) | NP level |
NCT05219370 | Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD | attention deficit hyperactivity disorder | Cannabinol (NPC16577) | NP level |
NCT03467620 | Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease | Crohn Disease|Inflammatory Bowel Diseases|Cannabis | Cannabis Sativa | Plant level As plant Extract |
NCT04129489 | A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis | Autoimmune Hepatitis | Cannabidiol (NPC299568) | NP level |
NCT03581058 | Neural Correlates of Driving and Cannabis | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT03215940 | Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) | Chronic pain | Cannabidiol (NPC299568) | NP level |
NCT02504151 | Cannabidiol Treatment in Patients With Early Psychosis | schizophrenia;schizoaffective disorder | Cannabidiol (NPC299568) | NP level |
NCT01969474 | Effectiveness of Cannabis in the Treatment of Tinnitus Patients | Tinnitus | Cannabinol (NPC16577) | NP level |
NCT05344170 | Cannabinol Use in Patients With Insomnia Disorder | insomnia | Cannabinol (NPC16577) | NP level |
NCT05392127 | A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers | rheumatoid arthritis | Phytonadione (NPC188844) | NP level |
NCT04477811 | Comparative Study Evaluating the Effect of Vitamin K1 Versus Vitamin K2 on Vascular Calcification in Dialysis Patients | chronic kidney disease | Phytonadione (NPC188844) | NP level |
NCT00308555 | Opioid and Cannabinoid Pharmacokinetic Interactions | pain | Cannabinol (NPC16577) | NP level |
NCT05015439 | CBD-OS) in Children and Adolescents With Autism Spectrum Disorder | autism spectrum disorder | Cannabidiol (NPC299568) | NP level |
NCT00248378 | Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT05317546 | Cannabidiol in Youth Alcohol Use Disorder | alcohol dependence | Cannabidiol (NPC299568) | NP level |
NCT02565108 | A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT05132699 | Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder | post-traumatic stress disorder | Cannabidiol (NPC299568) | NP level |
NCT00682929 | Cannabis for Spasticity in Multiple Sclerosis | Multiple Sclerosis | Cannabis Sativa | Plant level As single plant |
NCT03904849 | Cannabidiol for Alcohol Use Disorder | alcohol dependence | Cannabidiol (NPC299568) | NP level |
NCT01562483 | The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain | Abdominal pain;Chronic pain | Cannabinol (NPC16577) | NP level |
NCT02165176 | Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis | Cannabis | Cannabis Sativa | Plant level As single plant |
NCT03634189 | Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C | heart failure | Cannabidiol (NPC299568) | NP level |
NCT02063802 | Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children | obesity | Linoleic Acid (NPC85813) | NP level |
NCT04992962 | Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee | osteoarthritis, knee | Cannabidiol (NPC299568);Cannabinol (NPC16577) | NP level |
NCT04269993 | Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis | Rheumatoid Arthritis|Psoriatic Arthritis | Cannabis Sativa | Plant level As single plant |
NCT01232647 | Vitamin K as Additive Treatment in Osteoporosis | postmenopausal osteoporosis | Phytonadione (NPC188844) | NP level |
NCT05488509 | Acute Effects of Cannabis on Everyday Life Memory | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | Dravet syndrome | Cannabidiol (NPC299568) | NP level |
NCT04841993 | Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00373503 | Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04821856 | Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability | Intellectual disability | Cannabidiol (NPC299568) | NP level |
NCT00908791 | Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue | breast cancer | Linoleic Acid (NPC85813) | NP level |
NCT00255580 | Medicinal Cannabis for Painful HIV Neuropathy | neuropathic pain | Cannabinol (NPC16577) | NP level |
NCT04114903 | Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity | Type 2 Diabetes|Obesity|Cannabis Use|Insulin Sensitivity | Cannabis Sativa | Plant level As single plant |
NCT01792310 | A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours | glioma | Oleic Acid (NPC261831) | NP level |
NCT04124432 | Behavioral Pharmacology of Cannabis and Nicotine | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT03204305 | Brain Imaging of Cannabinoid Receptors | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04679545 | Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet | neuropathic pain | Cannabidiol (NPC299568) | NP level |
NCT04517799 | Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism | autism | Cannabidiol (NPC299568) | NP level |
NCT00607945 | Dietary Fatty Acids as Complementary Therapy in Type 2 Diabetes Mellitus | type 2 diabetes mellitus | Linoleic Acid (NPC85813) | NP level |
NCT04133480 | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome | Lennox-Gastaut syndrome | Cannabidiol (NPC299568) | NP level |
NCT03224468 | Effect of Medical Marijuana on Neurocognition and Escalation of Use | Pain|Insomnia|Depression|Anxiety | Cannabis Sativa | Plant level As single plant |
NCT03984565 | Sublingual Cannabidiol for Chronic Pain | Chronic pain | Cannabidiol (NPC299568) | NP level |
NCT02844933 | Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome | Prader-Willi syndrome | Cannabidiol (NPC299568) | NP level |
NCT04197102 | Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder | post-traumatic stress disorder | Cannabidiol (NPC299568) | NP level |
NCT05432206 | MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva | Dementia | Cannabinol (NPC16577) | NP level |
NCT02460692 | Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain | Cannabis|Low Back Pain|Neuropathic Pain | Cannabis Sativa | Plant level As plant Extract |
NCT03458416 | A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Patients With Prader-Willi Syndrome | Prader-Willi syndrome | Cannabidiol (NPC299568) | NP level |
NCT02675842 | Investigation of Cannabis for Pain and Inflammation in Lung Cancer | lung cancer | Cannabidiol (NPC299568) | NP level |
NCT04269993 | Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis | psoriatic arthritis | Cannabinol (NPC16577);Cannabidiol (NPC299568) | NP level |
NCT02607891 | A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy | epilepsy | Cannabidiol (NPC299568) | NP level |
NCT03310593 | Cannabidiol as an Adjunctive Treatment for Bipolar Depression | bipolar disorder | Cannabidiol (NPC299568) | NP level |
NCT01661764 | Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention | colorectal adenoma | Oleic Acid (NPC261831) | NP level |
NCT01311778 | Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse | opioid dependence | Cannabidiol (NPC299568) | NP level |
NCT00951158 | A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors | neoplasm | Linoleic Acid (NPC85813) | NP level |
NCT00628706 | Investigating the Acute Effects of THC on Functional Brain Systems | memory impairment | Cannabinol (NPC16577) | NP level |
NCT00072982 | Treatment of Rheumatoid Arthritis With Marine and Botanical Oils | rheumatoid arthritis | Gamolenic Acid (NPC5413) | NP level |
NCT02392780 | Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease | acute graft vs. host disease | Cannabidiol (NPC299568) | NP level |
NCT05411913 | Topical CBD for Musculoskeletal Pain | pain | Cannabidiol (NPC299568) | NP level |
NCT03246113 | Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma | glioblastoma multiforme | Cannabinol (NPC16577) | NP level |
NCT05020028 | Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis | osteoarthritis, knee | Cannabidiol (NPC299568) | NP level |
NCT04349930 | The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC) | interstitial cystitis | Cannabidiol (NPC299568) | NP level |
NCT01040910 | Cannabis for Inflammatory Bowel Disease | Crohn's Disease|Ulcerative Colitis | Cannabis Sativa | Plant level As single plant |
NCT04587791 | Cannabidiol in Opioid Use Disorder and Chronic Pain | Chronic pain | Cannabidiol (NPC299568) | NP level |
NCT03336242 | Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures | childhood absence epilepsy | Cannabidiol (NPC299568) | NP level |
NCT05170451 | Topical CBD for Musculoskeletal Pain | pain | Cannabidiol (NPC299568) | NP level |
NCT03805750 | Trial of Cannabis for Essential Tremor | essential tremor | Cannabidiol (NPC299568) | NP level |
NCT02478424 | Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease | graft versus host disease | Cannabidiol (NPC299568) | NP level |
NCT04611438 | Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome | Dravet syndrome | Cannabidiol (NPC299568) | NP level |
NCT02953548 | Trial of Cannabidiol (CBD | West syndrome | Cannabidiol (NPC299568) | NP level |
NCT02683018 | Investigation of Cannabis for Chronic Pain and Palliative Care | Chronic pain | Cannabidiol (NPC299568) | NP level |
NCT03421496 | A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms | developmental and epileptic encephalopathy | Cannabidiol (NPC299568) | NP level |
NCT02051387 | Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT04634136 | Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy | Children;Adult|Spastic Cerebral Palsy|Quality of Life|Cannabis|Physical Disability | Cannabis Sativa | Plant level As single plant |
NCT00806442 | Treatment of Bronchial Asthma With Borage and Echium Seed Oils | asthma | Gamolenic Acid (NPC5413) | NP level |
NCT01771731 | Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease | sickle cell anemia | Cannabinol (NPC16577) | NP level |
NCT05092191 | Cannabis as a Complementary Treatment in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT03550352 | Cannabinoids in PLWHIV on Effective ART | HIV infection | Cannabidiol (NPC299568) | NP level |
NCT04741477 | The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products | cannabis dependence | Cannabidiol (NPC299568) | NP level |
NCT04982965 | Brain Mechanisms Supporting Cannabis-induced Pain Relief | Chronic pain | Cannabinol (NPC16577) | NP level |
NCT01491490 | Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT04745026 | Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P | autism spectrum disorder | Cannabidiol (NPC299568) | NP level |
NCT02710097 | Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04231643 | Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers | bipolar disorder | Cannabidiol (NPC299568) | NP level |
NCT05016349 | Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. | breast cancer | Cannabidiol (NPC299568) | NP level |
NCT05445804 | Oral Cannabidiol for Tobacco Cessation | nicotine dependence | Cannabidiol (NPC299568) | NP level |
NCT03355300 | Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures | childhood absence epilepsy | Cannabidiol (NPC299568) | NP level |
NCT03929835 | Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa | hidradenitis suppurativa | Cannabinol (NPC16577) | NP level |
NCT03549819 | Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study | Generalized Anxiety Disorder|Social Anxiety Disorder|Panic Disorder|Agoraphobia | Cannabis Sativa | Plant level As plant Extract |
NCT00204932 | Effects of CLA Supplements on Body Weight and Fat Oxidation | obesity | Linoleic Acid (NPC85813) | NP level |
NCT04411225 | Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis | psychosis | Cannabidiol (NPC299568) | NP level |
NCT03546790 | Laboratory Smoking of Marijuana "Blunts" | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05299944 | Reducing Pain and Opioid Use With CBD | opioid use disorder | Cannabidiol (NPC299568) | NP level |
NCT04693884 | Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT00781001 | Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy | diabetic neuropathy | Cannabinol (NPC16577) | NP level |
NCT02088060 | A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT01844687 | Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana | nicotine dependence | Cannabidiol (NPC299568) | NP level |
NCT04731116 | Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection | COVID-19 | Cannabidiol (NPC299568) | NP level |
NCT05212493 | The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder | Autism Spectrum Disorder | Cannabis Sativa | Plant level As single plant |
NCT03102918 | Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder | cannabis dependence | Cannabidiol (NPC299568) | NP level |
NCT03802799 | Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS | fragile X syndrome | Cannabidiol (NPC299568) | NP level |
NCT02751359 | Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers | pain | Cannabidiol (NPC299568) | NP level |
NCT04878627 | Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa | anorexia nervosa | Cannabidiol (NPC299568) | NP level |
NCT05233761 | Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia | insomnia | Cannabidiol (NPC299568) | NP level |
NCT04816994 | Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement | Acute Radicular Back Pain|Cannabis | Cannabis Sativa | Plant level As plant Extract |
NCT03944447 | Outcomes Mandate National Integration With Cannabis as Medicine | AIDS;amyotrophic lateral sclerosis;anxiety;autism;bipolar disorder;brain injury;cancer;COVID-19;Crohn's disease;depressive disorder;fibromyalgia;glaucoma;hepatitis C virus infection;insomnia;opioid use disorder;Parkinson disease;post-traumatic stress disorder;Seizure;severe acute respiratory syndrome;sickle cell anemia;Tourette syndrome;ulcerative colitis;Chronic pain;epilepsy;multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT00743366 | Effect of Quetiapine on Marijuana Withdrawal and Relapse | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04226690 | Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products | pain | Cannabidiol (NPC299568) | NP level |
NCT00638196 | Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS | multiple sclerosis | Oleic Acid (NPC261831) | NP level |
NCT00062595 | Vitamin K and Bone Turnover in Postmenopausal Women | osteoporosis | Phytonadione (NPC188844) | NP level |
NCT02954887 | GWP42003-P) for Infantile Spasms (GWPCARE7) | West syndrome | Cannabidiol (NPC299568) | NP level |
NCT02759185 | Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD | post-traumatic stress disorder | Cannabinol (NPC16577);Cannabidiol (NPC299568) | NP level |
NCT03808935 | Cannabis Extract in Refractory Epilepsy Study | Drug Resistant Epilepsy | Cannabis Sativa | Plant level As plant Extract |
NCT04423341 | Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm | Benign essential blepharospasm | Cannabidiol (NPC299568) | NP level |
NCT02091206 | A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) | Dravet syndrome | Cannabidiol (NPC299568) | NP level |
NCT03252756 | Effects of Cannabidiol in Alcohol Use Disorder | alcohol dependence | Cannabidiol (NPC299568) | NP level |
NCT01771731 | Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease | Sickle Cell Disease | Cannabis Sativa | Plant level As plant Extract |
NCT05180240 | Impact of CardiolRx on Myocardial Recovery in Acute Myocarditis | myocarditis | Cannabidiol (NPC299568) | NP level |
NCT04978428 | Epidiolex in Obsessive Compulsive Disorder and Related Disorders | Hair-pulling;obsessive-compulsive disorder;Tourette syndrome | Cannabidiol (NPC299568) | NP level |
NCT02818777 | A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease | Parkinson's Disease | Cannabis Sativa | Plant level As plant Extract |
NCT00916201 | Evaluation Study of New Compounds With Potential Use in Schizophrenia | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT00682929 | Cannabis for Spasticity in Multiple Sclerosis | multiple sclerosis | Cannabinol (NPC16577) | NP level |
NCT03787628 | Cannabidiol as Adjunctive Treatment for Opioid Use Disorder | opioid use disorder | Cannabidiol (NPC299568) | NP level |
NCT05115318 | The Effect of Medical Cannabis on Tics;Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome | Tourette Syndrome|Cannabis | Cannabis Sativa | Plant level As single plant |
NCT05097651 | CBD for Sleep in People With HIV | Sleep Disorder | Cannabidiol (NPC299568) | NP level |
NCT02926859 | Enhancing Recovery in Early Schizophrenia | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT04686539 | Synthetic CBD as a Therapy for COVID-19 | COVID-19 | Cannabidiol (NPC299568) | NP level |
NCT04467918 | CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms | COVID-19 | Cannabidiol (NPC299568) | NP level |
NCT02539823 | Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans | opioid dependence | Cannabidiol (NPC299568) | NP level |
NCT04271917 | Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients | pain | Cannabidiol (NPC299568) | NP level |
NCT03247244 | Safety and Efficacy of Cannabis in Tourette Syndrome | Tourette Syndrome | Cannabis Sativa | Plant level As single plant |
NCT00309413 | A Clinical Trial on the Antipsychotic Properties of Cannabidiol | schizophrenia | Cannabidiol (NPC299568) | NP level |
NCT00377468 | Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) | complex regional pain syndrome | Cannabinol (NPC16577) | NP level |
NCT05184478 | Is Medicinal Cannabis an Effective Treatment for Tourette Syndrome in Adolescents? A Pilot Study | Tourette syndrome | Cannabidiol (NPC299568) | NP level |
NCT03676166 | Pharmacokinetic and Pharmacodynamic Effects of Smoked and Vaporized Cannabis | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT04911127 | Therapeutic Response of Cannabidiol in Rheumatoid Arthritis | Rheumatoid Arthritis|Cannabis | Cannabis Sativa | Plant level As plant Extract |
NCT05494788 | Impact of CardiolRxTM on Recurrent Pericarditis | pain | Cannabidiol (NPC299568) | NP level |
NCT04800159 | Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity | HIV|Cannabis Use | Cannabis Sativa | Plant level As single plant |
NCT04760613 | CBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT) | radiculopathy | Cannabidiol (NPC299568) | NP level |
NCT02517424 | Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder | post-traumatic stress disorder | Cannabidiol (NPC299568) | NP level |
NCT00588731 | Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia | schizophrenia;schizoaffective disorder | Cannabidiol (NPC299568) | NP level |
NCT02818777 | A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease | Parkinson disease | Cannabidiol (NPC299568) | NP level |
NCT02165176 | Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis | cannabis dependence | Cannabinol (NPC16577) | NP level |
NCT05076370 | Safety and Tolerability of Cannabidiol Among Persons With Opioid Use Disorder Receiving Methadone or Buprenorphine | drug dependence | Cannabidiol (NPC299568) | NP level |
NCT05317013 | CBD in Postmenopausal Women With Osteopenia | Osteopenia | Cannabidiol (NPC299568) | NP level |
NCT03848832 | Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | Rett syndrome | Cannabidiol (NPC299568) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
HTR2C,CHRM1,DRD3
NCT03582137,NCT02818777 NCT02818777,NCT03582137,NCT03944447,NCT03639064 |
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
FFAR4,CYP3A4,CNR2,ALOX15,CYP1B1,FABP5,CYP3A5,GPR55,HTR2C
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
CNR2
CHRM4 NCT01037322,NCT03467620,NCT01040910 NCT01037322,NCT03944447,NCT01040910 |
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B81 |
HTR2C,CNR1,PPARD,CHRM1
NCT04114903 NCT00204932,NCT02063802 |
Post-traumatic stress disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B40 |
NCT05132699,NCT02759185,NCT04197102,NCT03944447,NCT05269459,NCT03518801,NCT02517424
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
OR51E2,AKR1C3,FABP5,FABP4,CNR1,HTR2C,AKR1C3
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
CHRM1,CNR2,CYP2C19,CHRM4,ALOX15,CYP1A1,CNR1
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
CYP2B6,CNR2,CASP6,FABP3,FABP5,CYP3A5,HTR2C
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
OR51E2,CYP3A4,CHRM2,FFAR1,FABP3,FABP5,HTR2C
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT01037322,NCT01040910
NCT01562314,NCT01037322,NCT03944447,NCT01040910 |
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CNR2,CNR1
NCT03224468 NCT03944447,NCT05344170,NCT05233761 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
PPARA,PPARD,CNR1,FFAR1
NCT04114903 NCT00607945 |
Neuropathic painDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43.0 |
NCT00255580,NCT02460692
NCT05351801,NCT04679545,NCT00255580,NCT00254761 |
Tourette syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A05.00 |
NCT05115318,NCT03247244
NCT03944447,NCT04978428,NCT05184478,NCT03247244 |
Alcohol dependenceDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40.2 |
NCT03252756,NCT03904849,NCT04873453,NCT05387148,NCT05159830,NCT05317546
|
Dravet syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61.11 |
NCT02224703,NCT04611438,NCT02091206,NCT02318563,NCT03467113,NCT02091375
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
CYP3A4,DRD3,CHRM1,PPARA
NCT03617692 |
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
HTR2C,CNR2,GPR55,DRD3
NCT05219370 |
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
DRD3
NCT03944447,NCT03310593,NCT05457465,NCT04231643 |
Graft-versus-host diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B24 |
NCT03840512,NCT01596075,NCT02478424,NCT01385124,NCT02392780
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
OR51E2,CHRM1,CHRM2,CHRM4,FABP5
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
OR51E2,FABP3,FABP5,FABP4,CNR1
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NR1I2,FFAR1,FABP3,GPR55,HTR2C
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CYP2B6,ALOX15,CYP1A1,GPR55,HTR2C
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CHRM1,CYP3A4,CYP1A2,CYP1A1,CNR1
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
NCT04911127,NCT04269993
NCT00072982,NCT05392127 |
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
HTR2C
NCT05427630,NCT05337033,NCT04360044 |
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
CNR1,PPARA,FFAR1,HTR2C
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
HTR2C,CHRM1,PPARD,DRD3
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
CNR1
NCT04477811,NCT01528800,NCT05490511 |
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
CHRM4,CHRM2
NCT00029679,NCT00806442 |
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
CHRM2,CHRM4,CHRM1
NCT03944447 |
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04686539,NCT04731116,NCT03944447,NCT04467918
|
Osteoarthritis of kneeDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA01 |
NCT05020028,NCT02324777,NCT04992624,NCT04992962
|
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
OR51E2,FABP5,ALOX15
NCT04428203 |
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
OR51E2,FABP5,CNR1,LMNA
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CYP2B6,CYP3A4,CYP1A2,HTR2C
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
CYP2B6,AKR1C3,NR1I2,HTR2C
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
LMNA,CYP1B1,FABP5,CYP3A5
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
DRD3,HTR2C
NCT03224468 |
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT04800159
NCT03550352,NCT05306249 |
Obsessive-compulsive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B20 |
NCT03274440
NCT04978428,NCT03274440 |
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT01771731
NCT03944447,NCT01771731 |
Inborn lipid metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52 |
CNR1,CNR2,PPARA
|
DyslipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80-5C81 |
CHRM1,PPARA,PPARD
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
CNR1
NCT01844687,NCT05445804 |
Schizoaffective disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A21 |
CHRM1
NCT02504151,NCT00588731 |
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
PPARA,PPARD
FABP4 |
Chronic widespread painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.01 |
NCT03944447,NCT04729179,NCT05283161
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT03944447,NCT01776970,NCT03690791
|
Fragile X chromosomeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD55 |
NCT03614663,NCT03802799,NCT04977986
|
Lennox-Gastaut syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62.1 |
NCT04133480,NCT02318537,NCT02224690
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
AKR1C3,FABP4,HTR2C
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
OR51E2,AKR1C3,HTR2C
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
CYP3A5,FABP3,LMNA
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
CHRM4,FFAR1,LMNA
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CYP2B6,CNR2,HTR2C
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
CNR2,CNR1,FFAR1
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
OR51E2,FFAR4,CYP1B1
|
Cannabis use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C41 |
CNR1
NCT02710097,NCT04693884,NCT04601207,NCT05276232,NCT04741477,NCT03102918,NCT05049733,NCT00743366,NCT00373503,NCT02955329,NCT02165176,NCT03676166,NCT02177513,NCT03204305,NCT04841993,NCT00373295,NCT02083874,NCT05488509,NCT03581058,NCT05407285,NCT04124432,NCT02044809,NCT03546790,NCT03766971,NCT05320367,NCT03253926 |
Hidradenitis suppurativaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED92 |
NCT03929835
NCT03929835 |
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34.2 |
AKR1C3
NCT05670353 |
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
FABP4
NCT03245658 |
Essential tremor or related tremorsDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04.1 |
NCT03805750
NCT03805750 |
Chronic peripheral neuropathic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.51 |
NCT00781001,NCT03099005
|
TinnitusDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC41 |
NCT01969474
NCT01969474 |
Psoriatic arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA21 |
NCT04269993
NCT04269993 |
Anorexia nervosaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B80 |
CNR1
NCT04878627 |
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
CHRM2,CHRM4
|
Abdominal pelvic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD81 |
CHRM1
NCT01562483 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
CNR1
NCT01661764 |
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
PPARA
NCT01742273 |
Nausea/vomitingDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90 |
CNR1,CHRM4
|
Peptic ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA61 |
CHRM1,CHRM2
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
PPARD,CNR1
|
Abnormal micturitionDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF50 |
CHRM1,CHRM2
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
CNR2,CYP3A4
|
Sebaceous gland disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED91 |
CHRM2,CHRM1
|
Psychoactive substances use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4G |
DRD3,HTR2C
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
CHRM1
NCT05432206 |
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PPARD,PPARA
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
CNR2,CHRM1
|
Epileptic encephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62 |
CHRM1
NCT03421496 |
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
AKR1C3
NCT04676035 |
Diabetic polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C03.0 |
NCT04088929,NCT00781001
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
NCT05016349,NCT00908791
|
Infantile spasmsDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62.0 |
NCT02954887,NCT02953548
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT03246113,NCT04752813
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT02255292,NCT00951158
|
Prader-Willi syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD90.3 |
NCT02844933,NCT03458416
|
Syndromes with vascular anomalies as a major featureDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD23 |
NCT02332655,NCT04447846
|
Childhood absence epilepsyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61.21 |
NCT03336242,NCT03355300
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT03825965,NCT04412837
|
Rett syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD90.4 |
NCT04252586,NCT03848832
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
NR1I2,DRD3
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
ALOX15,HTR2C
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
CYP1A1,HTR2C
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
AKR1C3,HTR2C
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
CYP2B6,ALOX15
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
FFAR1,CYP1A1
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CYP1B1,FFAR1
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
FABP4,CNR1
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
HTR2C,CNR1,CNR2
NCT03948074,NCT03224468,NCT03099005,NCT00308555 NCT03877991,NCT02751359,NCT00308555,NCT05170451,NCT04193631,NCT04271917,NCT04226690,NCT05240755,NCT05411913,NCT05494788 |
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
NCT03808935
NCT03944447,NCT02324673,NCT05288283,NCT02318602,NCT02607904,NCT02224560,NCT02565108,NCT04280289,NCT02607891,NCT02564952,NCT03808935,NCT02286986,NCT02783092,NCT03944447 |
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
HTR2C,CHRM1,DRD3
NCT00588731,NCT02088060,NCT02926859,NCT01491490,NCT00309413,NCT02504151,NCT00916201,NCT02051387,NCT00628290,NCT02006628,NCT04421456 |
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
OR51E2,CYP2B6,FFAR4,AKR1C3,CNR2,NR1I2,CHRM4,PPARD,CYP1B1,FABP3,ALOX15,CYP2C19,GPR55,LMNA
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
NCT03522324
NCT03944447,NCT01562483,NCT04587791,NCT02683018,NCT04044729,NCT03984565,NCT03215940,NCT03635593,NCT05288010,NCT04982965 |
Opioid use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C43 |
NCT03944447,NCT03787628,NCT05114460,NCT01311778,NCT01605539,NCT04238754,NCT02539823,NCT04192370,NCT04238754,NCT05299944,NCT04982029
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CHRM1,FFAR4,ALOX15,NR1I2,CHRM4,CASP6,CYP1A2,FABP3,FABP5,GPR55,HTR2C
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
OR51E2,PPARA,CNR2,NR1I2,FFAR1,CASP6,FABP3,FABP5,FABP4,CNR1,LMNA
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
OR51E2,CNR1,FFAR4,CNR2,CHRM4,FFAR1,CASP6,ALOX15,CYP3A5,GPR55,LMNA
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NCT00260741,NCT03172741,NCT00682929,NCT00248378
NCT00682929,NCT05092191,NCT00260741,NCT00248378,NCT03944447,NCT00638196 |
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
CYP3A4,HTR2C
NCT03948074,NCT03224468 NCT03944447,NCT04286594,NCT02548559,NCT05257044,NCT05283382,NCT04267679 |
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
NCT05212493,NCT05413187
NCT03900923,NCT04745026,NCT05015439,NCT04520685,NCT05212493,NCT03944447,NCT05413187,NCT04517799 |
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
CYP2B6,CHRM1,FFAR4,ALOX15,NR1I2,CHRM4,FFAR1,CASP6,FABP5,HTR2C
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
FFAR4,FABP5,CYP3A5,CNR1,OR51E2,CNR1,FFAR4,FABP5,CYP3A5,GPR55
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
NCT03467620
|
AgoraphobiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B02 |
NCT03549819
|
Generalised anxiety disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B00 |
NCT03549819
|
Panic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B01 |
NCT03549819
|
Social anxiety disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B04 |
NCT03549819
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
NCT05670353
|
AnorexiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG43.7 |
NCT03245658
|
Malignant cachexiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG20.0 |
NCT03245658
|
Unknown and unspecified causes of morbidityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG48 |
NCT03245658
|
NauseaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD90.0 |
NCT03948074
|
Sleep disturbance, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG41 |
NCT03948074
|
Limited function or disability of body organ or systemDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QF10 |
NCT04634136
|
Spastic cerebral palsyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D20 |
NCT04634136
|
Chronic primary musculoskeletal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.02 |
NCT03522324
|
Spinal pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.Z |
NCT04816994
|
RestlessnessDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.F |
NCT03328676
|
Other specified atypical parkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00.1Y |
NCT04360044
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT02460692
|
Intellectual development disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD90 |
CHRM1
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
DRD3
|
Sexual dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA00-HA01 |
DRD3
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
HTR2C
|
Functional bladder disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC50 |
CHRM1
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
PPARA
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
PPARA
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
DRD3
|
HyperhidrosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EE00 |
CHRM1
|
HyperlipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PPARA
|
Autoimmune liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96 |
PPARD
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
CHRM1
|
Tonus and reflex abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47 |
HTR2C
|
Acute upper respiratory infectionDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA07 |
DRD3
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
DRD3
|
Sleep-wake disorderDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7B2Z |
HTR2C
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
CHRM1
|
Dystonic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A02 |
CHRM1
|
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
DRD3
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CHRM1
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
HTR2C
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
CHRM1
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
HTR2C
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
DRD3
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
DRD3
|
Muscle disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB32-FB3Z |
CHRM2
|
Gastroduodenal motor/secretory disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA41 |
DRD3
|
Gastric ulcerDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA60 |
CHRM1
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
DRD3
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
HTR2C
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
FFAR1
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
CNR1
|
Eye anterior segment structural developmental anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA11 |
CHRM4
|
Chronic insomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00 |
HTR2C
|
Corneal diseaseDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A76-9A78 |
CHRM1
|
Cervical spine painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.0 |
NCT02892591
|
Underweight in adultsDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B54 |
NCT03664141
|
Intracranial injury, unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07.Z |
NCT03944447
|
Benign essential blepharospasmDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A02.00 |
NCT04423341
|
Huntington diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01.10 |
NCT01502046
|
Schizophrenia or other primary psychotic disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A2Z |
NCT04411225
|
Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4G.2Z |
NCT05076370
|
Cramp or spasmDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47.3 |
NCT00552604
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT03944447
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
NCT02892591
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT01792310
|
Complex regional pain syndromeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.04 |
NCT00377468
|
MyocarditisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC42 |
NCT05180240
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NCT03634189
|
Migraine disorder(TM1)Disease Category: 26.Supplementary Chapter Traditional Medicine Conditions - Module IDisease ICD-11 Code: SD10 |
NCT03972124
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT03944447
|
RadiculopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B93 |
NCT04760613
|
Injury of spinal cord, level unspecifiedDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51.2 |
NCT01555983
|
TrichotillomaniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B25.0 |
NCT04978428
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
NCT05346562
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT03944447
|
OsteopeniaDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83.0 |
NCT05317013
|
Pain in jointDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME82 |
NCT05002114
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT03944447
|
Chronic hepatitis B, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.0Z |
NCT05273775
|
Circadian rhythm sleep disorderDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A60-7A65 |
NCT05097651
|
Age-associated cognitive declineDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.0 |
NCT00628706
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT02675842
|
Status epilepticusDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A66 |
NCT04721691
|
Symptoms and signs involving cognition, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.Z |
NCT04590495
|
Cocaine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C45 |
NCT02559167
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
NCT03388970
|
Other specified non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.Y |
NCT01284634
|
Autoimmune hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.0 |
NCT04129489
|
Interstitial cystitisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC00.3 |
NCT04349930
|
Other specified disorders of teeth and supporting structuresDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA0A.Y |
NCT04642404
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT04582591
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT04883255
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT03944447
|
Disorders of intellectual development, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A00.Z |
NCT04821856
|
OsteoporosisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83.1 |
NCT00062595
|
Postmenopausal osteoporosisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83.11 |
NCT01232647
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
CYP1A1
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
FABP5
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
CNR2
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1
|
Malignant neoplasms of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
FABP4
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
FABP4
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CYP1A1
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
FFAR4
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
AKR1C3
|